Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

FRESENIUS KABI USA

  • FDA Approval
  • Feb. 27, 2023, 13:18 UTC
  • 28
  • 0 comments

FDA approve AMIKACIN SULFATE

Comment Full text

GLAND PHARMA LTD

  • FDA Approval
  • Feb. 27, 2023, 13:18 UTC
  • 30
  • 0 comments

FDA approve TOBRAMYCIN SULFATE

Comment Full text

XGEN PHARMS

  • FDA Approval
  • Feb. 27, 2023, 13:18 UTC
  • 27
  • 0 comments

FDA approve STREPTOMYCIN SULFATE

Comment Full text

TEVA PHARMS USA

  • FDA Approval
  • Feb. 27, 2023, 13:18 UTC
  • 28
  • 0 comments

FDA approve AMIKACIN SULFATE

Comment Full text

TEVA PHARMS USA

  • FDA Approval
  • Feb. 27, 2023, 13:18 UTC
  • 27
  • 0 comments

FDA approve TOBRAMYCIN SULFATE

Comment Full text

FRESENIUS KABI USA

  • FDA Approval
  • Feb. 27, 2023, 13:18 UTC
  • 29
  • 0 comments

FDA approve GENTAMICIN SULFATE

Comment Full text

XGEN PHARMS

  • FDA Approval
  • Feb. 27, 2023, 13:18 UTC
  • 27
  • 0 comments

FDA approve NEOMYCIN SULFATE

Comment Full text

FRESENIUS KABI USA

  • FDA Approval
  • Feb. 27, 2023, 13:18 UTC
  • 30
  • 0 comments

FDA approve TOBRAMYCIN SULFATE

Comment Full text

FRESENIUS KABI USA

  • FDA Approval
  • Feb. 27, 2023, 13:18 UTC
  • 29
  • 0 comments

FDA approve TOBRAMYCIN SULFATE

Comment Full text

XGEN PHARMS

  • FDA Approval
  • Feb. 27, 2023, 13:18 UTC
  • 27
  • 0 comments

FDA approve TOBRAMYCIN SULFATE

Comment Full text
  • Previous
  • 874
  • 875
  • 876
  • 877
  • 878
  • Next

Search

News categories

  • Technical Exchange News(12226)
  • Event(6167)
  • SEC News(263071)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(154441)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin